These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22710695)

  • 21. Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD).
    Dörr K; Kammer M; Reindl-Schwaighofer R; Lorenz M; Loewe C; Marculescu R; Erben R; Oberbauer R
    Trials; 2019 Oct; 20(1):601. PubMed ID: 31651370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone is associated with the LV mass after aortic valve replacement.
    Laflamme MH; Mahjoub H; Mahmut A; Boulanger MC; Larose E; Pibarot P; Mathieu P
    Heart; 2014 Dec; 100(23):1859-64. PubMed ID: 25095827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlates of left ventricular mass in chronic hemodialysis recipients.
    Wald R; Goldstein MB; Wald RM; Harel Z; Kirpalani A; Perl J; Yuen DA; Wolf MS; Yan AT
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):349-56. PubMed ID: 24293047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating the role of cardiovascular biomarkers in children with pre-dialysis chronic kidney disease: a substitute to echocardiography to detect increased left ventricular mass?
    Clothier JC; Simpson JM; Turner C; Dalton RN; Rasmussen P; Rawlins D; Booth CJ; Peacock JL; Sinha MD
    Nephron Clin Pract; 2013; 124(3-4):191-201. PubMed ID: 24401719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study.
    Kim JY; Lee Y; Kang HG; Ha IS; Cheong HI; Choi HJ; Han KH; Kim SH; Cho MH; Shin JI; Lee JH; Park YS; Cho H
    BMC Nephrol; 2020 Dec; 21(1):533. PubMed ID: 33297989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients.
    Bakkaloğlu SA; Kandur Y; Serdaroğlu E; Noyan A; Bayazıt AK; Taşdemir M; Özlü SG; Özçelik G; Dursun İ; Alparslan C; Akcaboy M; Atikel YÖ; Parmaksız G; Atmış B; Sever L
    Pediatr Nephrol; 2018 Nov; 33(11):2143-2150. PubMed ID: 30105415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between plasma fibroblast growth factor-23 and subclinical cardiovascular damages in children with primary hypertension].
    Lin Y; Shi L; Liu YY; Zhang HW; Liu Y; Zhang MM; Huang XL; Hou DQ; Cui XD
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):471-476. PubMed ID: 31216806
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.
    Hsu HJ; Wu MS
    Am J Med Sci; 2009 Feb; 337(2):116-22. PubMed ID: 19214027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
    Matsumoto M; Io H; Furukawa M; Okumura K; Masuda A; Seto T; Takagi M; Sato M; Nagahama L; Omote K; Hisada A; Horikoshi S; Tomino Y
    J Nephrol; 2012; 25(5):794-801. PubMed ID: 22241636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating fibroblast growth factor 23 in children on peritoneal dialysis is associated with effective dialysis.
    Hacıhamdioğlu DÖ; Düzova A; Alehan D; Oğuz B; Beşbaş N
    Turk J Pediatr; 2015; 57(1):9-16. PubMed ID: 26613215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of galectin-3 to left ventricular geometry and hypertrophy in chronic hemodialysis patients.
    Yilmaz H; Gurel OM; Celik HT; Bozkurt A; Yildirim ME; Bilgic I; Bilgic MA; Bavbek N; Akcay A
    Herz; 2015 Jun; 40(4):702-8. PubMed ID: 24924396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
    Sakuragi S; Ichikawa K; Yamada K; Tanimoto M; Miki T; Otsuka H; Yamamoto K; Kawamoto K; Katayama Y; Tanakaya M; Ito H
    Int J Cardiol; 2015; 190():287-92. PubMed ID: 25932809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention.
    Levin A; Singer J; Thompson CR; Ross H; Lewis M
    Am J Kidney Dis; 1996 Mar; 27(3):347-54. PubMed ID: 8604703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients.
    Kirkpantur A; Balci M; Gurbuz OA; Afsar B; Canbakan B; Akdemir R; Ayli MD
    Nephrol Dial Transplant; 2011 Apr; 26(4):1346-54. PubMed ID: 20813767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular hypertrophy and LV geometry in chronic dialysis children and adolescents.
    Lumpaopong A; Tuntrakool C; Thirakhupt P; Chulamokha Y
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S202-5. PubMed ID: 16858959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D levels and other biochemical parameters of mineral bone disorders and their association with diastolic dysfunction and left ventricular mass in young nondiabetic adult patients with chronic kidney disease.
    Sonkar SK; Bhutani M; Sonkar GK; Pandey SK; Chandra S; Bhosale V
    Saudi J Kidney Dis Transpl; 2017; 28(4):758-763. PubMed ID: 28748877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Left Ventricular Mass Index and Cardiovascular Compromise in children on dialysis].
    Sugg H C; Cano Sch F
    Rev Chil Pediatr; 2020 Dec; 91(6):917-923. PubMed ID: 33861828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the Method of Definition on the Prevalence of Left-Ventricular Hypertrophy in Children with Chronic Kidney Disease: Data from the Know-Ped CKD Study.
    Cho H; Choi HJ; Kang HG; Ha IS; Cheong HI; Han KH; Kim SH; Cho MH; Shin JI; Lee JH; Park YS
    Kidney Blood Press Res; 2017; 42(3):406-415. PubMed ID: 28689198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.